Table 13.1 Classification of acute myeloid leukaemia (AML) according to the WHO classification[removed]modified). Acute myeloid leukaemia with recurrent genetic abnormalities AML with t(8;21)(q22;q22); RUNX1-RUNX1T1

First Page		Document Content
Date: 2011-02-25 06:19:27 Acute myeloid leukemia Acute promyelocytic leukemia RUNX1 Myelodysplastic syndrome CEBPA Leukemia Acute panmyelosis with myelofibrosis Auer rod Myeloid sarcoma Myeloid leukemia Medicine Acute leukemia		Table 13.1 Classification of acute myeloid leukaemia (AML) according to the WHO classification[removed]modified). Acute myeloid leukaemia with recurrent genetic abnormalities AML with t(8;21)(q22;q22); RUNX1-RUNX1T1 Add to Reading List Source URL: www.essentialhaematology6.com Download Document from Source Website File Size: 118,14 KB Share Document on Facebook

	MDACC LEUKEMIA AND LYMPHOMA Europe and the USA Linking Knowledge and Practice DocID: 1vhjk - View Document
	Genome-wide mapping of proviral integration sites in aggresive virus-induced leukemia Nicolas Rosewick1,2, Vincent Hahaut1, Maria Artesi1, Keith Durkin1, Ambroise Marçais3, Philip Griebel4, Natasa Arsic4, Véronique Ave DocID: 1vcJH - View Document
	Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells Lijuan Xia, Duo Chen, Rui Han, et al. Mol Cancer Ther 2005;4:Updated version DocID: 1v6bB - View Document
	The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2 DocID: 1uSbg - View Document
$A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan$	A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan DocID: 1uJQ2 - View Document